Key result
The abstract text is unavailable, so no findings can be extracted.
No takes yet. Share an insight, caveat, or question.
Once-daily β-blockade feasible in hypertension; leaves open optimal regimens versus contemporary agents in outcome trials.
Mann et al. (1979) studied Hypertension. Once Daily β-Adrenoreceptor Blockade was evaluated. The abstract text is unavailable, so no findings can be extracted.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: